On July 28, 2026, Swiss technology innovation centre CSEM and biosensing company B-Secur announced a partnership to integrate clinically-validated heart monitoring into wearable devices. The collaboration combines CSEM's photoplethysmography (PPG) expertise with B-Secur's FDA-cleared electrocardiogram (ECG) algorithms. This multimodal solution addresses a growing wearable healthcare market, projected to expand from $45 billion in 2025 to $76 billion by 2030, by enhancing remote patient monitoring and arrhythmia detection.
B-Secur CSEM collaboration
- ▪B-Secur and CSEM announced a partnership on July 28, 2026, to bring clinically-validated heart monitoring capability to health wearables.
- ▪The collaboration combines CSEM's photoplethysmography-based vital signs monitoring with B-Secur's electrocardiogram analytics to enable multimodal sensing solutions.
PPG optical sensing technology
- ▪Photoplethysmography technology can flag irregular pulse patterns but has limited ability to accurately classify specific arrhythmia types beyond atrial fibrillation.
- ▪Photoplethysmography technology enables continuous monitoring of blood oxygen, heart rate, and heart rate variability in consumer health wearables.
ECG rhythm analysis algorithms
- ▪Electrocardiogram technology provides precision to confirm or rule out atrial fibrillation, supraventricular tachycardias, ventricular tachycardias, and premature ventricular contractions.
- ▪B-Secur contributes medical-grade electrocardiogram signal processing, rhythm analysis, and signal chain design expertise to the partnership.
FDA regulatory clearances
- ▪B-Secur holds multiple Food and Drug Administration 510(k) clearances and ISO 13485:2016 certification for its electrocardiogram algorithms and analytics.
- ▪B-Secur provides end-to-end support for regulatory navigation to device manufacturers and digital health companies.
Wearable healthcare market growth
- ▪The global wearable healthcare devices market is projected to grow from $45 billion in 2025 to nearly $76 billion by 2030.
- ▪Clinical-grade cardiac monitoring is identified as a key growth driver for the global wearable healthcare devices market.
Remote patient monitoring applications
- ▪The integrated solution from B-Secur and CSEM targets applications including remote patient monitoring, cardiovascular health, and chronic disease management.
- ▪CSEM offers a clinically validated portfolio of licensable vital signs algorithms including blood pressure, SpO2, respiratory rate, and sleep monitoring.
Story comments
Loading comments…